Skip to main content
Top
Published in: Health Research Policy and Systems 1/2017

Open Access 01-12-2017 | Research

The impact on healthcare, policy and practice from 36 multi-project research programmes: findings from two reviews

Authors: Steve Hanney, Trisha Greenhalgh, Amanda Blatch-Jones, Matthew Glover, James Raftery

Published in: Health Research Policy and Systems | Issue 1/2017

Login to get access

Abstract

Background

We sought to analyse the impacts found, and the methods used, in a series of assessments of programmes and portfolios of health research consisting of multiple projects.

Methods

We analysed a sample of 36 impact studies of multi-project research programmes, selected from a wider sample of impact studies included in two narrative systematic reviews published in 2007 and 2016. We included impact studies in which the individual projects in a programme had been assessed for wider impact, especially on policy or practice, and where findings had been described in such a way that allowed them to be collated and compared.

Results

Included programmes were highly diverse in terms of location (11 different countries plus two multi-country ones), number of component projects (8 to 178), nature of the programme, research field, mode of funding, time between completion and impact assessment, methods used to assess impact, and level of impact identified.
Thirty-one studies reported on policy impact, 17 on clinician behaviour or informing clinical practice, three on a combined category such as policy and clinician impact, and 12 on wider elements of impact (health gain, patient benefit, improved care or other benefits to the healthcare system). In those multi-programme projects that assessed the respective categories, the percentage of projects that reported some impact was policy 35% (range 5–100%), practice 32% (10–69%), combined category 64% (60–67%), and health gain/health services 27% (6–48%).
Variations in levels of impact achieved partly reflected differences in the types of programme, levels of collaboration with users, and methods and timing of impact assessment. Most commonly, principal investigators were surveyed; some studies involved desk research and some interviews with investigators and/or stakeholders. Most studies used a conceptual framework such as the Payback Framework. One study attempted to assess the monetary value of a research programme’s health gain.

Conclusion

The widespread impact reported for some multi-project programmes, including needs-led and collaborative ones, could potentially be used to promote further research funding. Moves towards greater standardisation of assessment methods could address existing inconsistencies and better inform strategic decisions about research investment; however, unresolved issues about such moves remain.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. The World Health Report 2013: Research for Universal Health Coverage. Geneva: WHO; 2013. World Health Organization. The World Health Report 2013: Research for Universal Health Coverage. Geneva: WHO; 2013.
3.
go back to reference Angulo-Tuesta A, Santos LMP. Evaluation of the impact of maternal and neonatal morbidity and mortality research funded by the Ministry of Health in Brazil. Res Eval. 2015;24:355–68. doi:10.1093/reseval/rvv022.CrossRef Angulo-Tuesta A, Santos LMP. Evaluation of the impact of maternal and neonatal morbidity and mortality research funded by the Ministry of Health in Brazil. Res Eval. 2015;24:355–68. doi:10.​1093/​reseval/​rvv022.CrossRef
9.
go back to reference Raftery J, Hanney S, Greenhalgh T, Glover M, Blatch-Jones A. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme. Health Technol Assess. 2016;20:76.CrossRef Raftery J, Hanney S, Greenhalgh T, Glover M, Blatch-Jones A. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme. Health Technol Assess. 2016;20:76.CrossRef
10.
go back to reference Canadian Academy of Health Sciences (CAHS). Making an Impact, A Preferred Framework and Indicators to Measure Returns on Investment in Health Research. Ottawa, ON: CAHS; 2009. Canadian Academy of Health Sciences (CAHS). Making an Impact, A Preferred Framework and Indicators to Measure Returns on Investment in Health Research. Ottawa, ON: CAHS; 2009.
12.
go back to reference Guthrie S, Wamae W, Diepeveeen S, Wooding S, Grant J. Measuring Research: A Guide to Research Evaluation Frameworks and Tools. Santa Monica, CA: RAND Corporation; 2013. Guthrie S, Wamae W, Diepeveeen S, Wooding S, Grant J. Measuring Research: A Guide to Research Evaluation Frameworks and Tools. Santa Monica, CA: RAND Corporation; 2013.
14.
go back to reference Buxton M, Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy. 1996;1:35–43.PubMed Buxton M, Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy. 1996;1:35–43.PubMed
16.
go back to reference Kogan M, Henkel M. Government and Research: The Rothschild Experiment in a Government Department. London: Heinemann Educational Books; 1983. Kogan M, Henkel M. Government and Research: The Rothschild Experiment in a Government Department. London: Heinemann Educational Books; 1983.
18.
go back to reference Weiss C. The many meanings of research utilization. Public Admin Rev. 1979;39:426–31.CrossRef Weiss C. The many meanings of research utilization. Public Admin Rev. 1979;39:426–31.CrossRef
19.
go back to reference Trostle J, Bronfman M, Langer A. How do researchers influence decision-makers? Case studies of Mexican policies. Health Policy Plan. 1999;14:103–14.CrossRefPubMed Trostle J, Bronfman M, Langer A. How do researchers influence decision-makers? Case studies of Mexican policies. Health Policy Plan. 1999;14:103–14.CrossRefPubMed
21.
go back to reference Lavis JN, Ross SE, Hurley JE, Hohenadel JM, Stoddart GL, Woodward CA, et al. Examining the role of health services research in public policymaking. Milbank Q. 2002;80:125–54.CrossRefPubMedPubMedCentral Lavis JN, Ross SE, Hurley JE, Hohenadel JM, Stoddart GL, Woodward CA, et al. Examining the role of health services research in public policymaking. Milbank Q. 2002;80:125–54.CrossRefPubMedPubMedCentral
22.
go back to reference Gilson L, Bowa C, Brijlal V, Doherty J, Antezana I, Daura M, et al. The Dynamics of Policy Change: Lessons From Health Financing Reform in South Africa and Zambia. Bethesda: Partnerships for Health Reform Project, Abt Associates Inc.; 2000. Gilson L, Bowa C, Brijlal V, Doherty J, Antezana I, Daura M, et al. The Dynamics of Policy Change: Lessons From Health Financing Reform in South Africa and Zambia. Bethesda: Partnerships for Health Reform Project, Abt Associates Inc.; 2000.
23.
go back to reference Spaapen J, van Drooge L. Introducing ‘productive interactions’ in social impact assessment. Res Eval. 2011;20:211–8.CrossRef Spaapen J, van Drooge L. Introducing ‘productive interactions’ in social impact assessment. Res Eval. 2011;20:211–8.CrossRef
25.
go back to reference Walt G. Health Policy: An Introduction to Process and Power. London: Zed Books; 1994. Walt G. Health Policy: An Introduction to Process and Power. London: Zed Books; 1994.
26.
go back to reference Sauerborn R, Nitayarumphong S, Gerhardus A. Strategies to enhance the use of health systems research for health sector reform. Trop Med Int Health. 1999;4:827–35.CrossRefPubMed Sauerborn R, Nitayarumphong S, Gerhardus A. Strategies to enhance the use of health systems research for health sector reform. Trop Med Int Health. 1999;4:827–35.CrossRefPubMed
29.
go back to reference Haines A, Kuruvilla S, Borchert M. Bridging the implementation gap between knowledge and action for health. Bull World Health Organ. 2004;82:724–31.PubMedPubMedCentral Haines A, Kuruvilla S, Borchert M. Bridging the implementation gap between knowledge and action for health. Bull World Health Organ. 2004;82:724–31.PubMedPubMedCentral
33.
go back to reference Alberta Heritage Foundation for Medical Research (AHFMR). Assessment of Health Research Fund Outputs and Outcomes: 1995–2003. Edmonton: AHFMR; 2003. Alberta Heritage Foundation for Medical Research (AHFMR). Assessment of Health Research Fund Outputs and Outcomes: 1995–2003. Edmonton: AHFMR; 2003.
36.
go back to reference Buxton M, Hanney S, Packwood T, Roberts S, Youll P. Assessing benefits from Department of Health and National Health Service research and development. Public Money Manag. 2000;20:29–34.CrossRef Buxton M, Hanney S, Packwood T, Roberts S, Youll P. Assessing benefits from Department of Health and National Health Service research and development. Public Money Manag. 2000;20:29–34.CrossRef
39.
go back to reference Expert Panel for Health Directorate of the European Commission’s Research Innovation Directorate General. Review of Public Health Research Projects Financed under the Commission’s Framework Programmes for Health Research. Brussels: European Commission; 2013. Expert Panel for Health Directorate of the European Commission’s Research Innovation Directorate General. Review of Public Health Research Projects Financed under the Commission’s Framework Programmes for Health Research. Brussels: European Commission; 2013.
40.
go back to reference Ferguson B, Kelly P, Georgiou A, Barnes G, Sutherland B, Woodbridge B. Assessing payback from NHS reactive research programmes. J Manage Med. 2000;14:25–36.CrossRef Ferguson B, Kelly P, Georgiou A, Barnes G, Sutherland B, Woodbridge B. Assessing payback from NHS reactive research programmes. J Manage Med. 2000;14:25–36.CrossRef
43.
go back to reference Hailey DM, Cowley DE, Dankiw W. The impact of health technology assessment. Commun Health Stud. 1990;14:223–34.CrossRef Hailey DM, Cowley DE, Dankiw W. The impact of health technology assessment. Commun Health Stud. 1990;14:223–34.CrossRef
44.
go back to reference Hailey D, Corabian P, Harstall C, Schneider W. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16:651–6.CrossRefPubMed Hailey D, Corabian P, Harstall C, Schneider W. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16:651–6.CrossRefPubMed
46.
go back to reference Hera. End of Programme Summative Evaluation of the Africa Health Systems Initiative Support to African Research Partnerships (AHSI-RES). Reet: Hera; 2014. Hera. End of Programme Summative Evaluation of the Africa Health Systems Initiative Support to African Research Partnerships (AHSI-RES). Reet: Hera; 2014.
47.
go back to reference Jacob R, Battista R. Assessing technology assessment. Int J Technol Assess Health Care. 1993;9:564–72.CrossRefPubMed Jacob R, Battista R. Assessing technology assessment. Int J Technol Assess Health Care. 1993;9:564–72.CrossRefPubMed
48.
go back to reference Jacob R, McGregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care. 1997;13:68–80.CrossRefPubMed Jacob R, McGregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care. 1997;13:68–80.CrossRefPubMed
50.
go back to reference Kingwell BA, Anderson GP, Duckett SJ, Hoole EA, Jackson-Pulver LR, Khachigian LM, et al. Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth. Med J Aust. 2006;184:282–6.PubMed Kingwell BA, Anderson GP, Duckett SJ, Hoole EA, Jackson-Pulver LR, Khachigian LM, et al. Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth. Med J Aust. 2006;184:282–6.PubMed
52.
go back to reference McGregor M, Brophy M. End-user involvement in health technology assessment (HTA) development: a way to increase impact. Int J Technol Assess Health Care. 2005;21:263–7.PubMed McGregor M, Brophy M. End-user involvement in health technology assessment (HTA) development: a way to increase impact. Int J Technol Assess Health Care. 2005;21:263–7.PubMed
54.
go back to reference Molas-Gallart J, Tang P, Morrow S. Assessing the non-academic impact of grant-funded socioeconomic research: results from a pilot study. Res Eval. 2000;9:171–82.CrossRef Molas-Gallart J, Tang P, Morrow S. Assessing the non-academic impact of grant-funded socioeconomic research: results from a pilot study. Res Eval. 2000;9:171–82.CrossRef
56.
go back to reference Poortvliet EP, Vijfvinkel D, Vennekens A, van Hoesel P, Daue F. Study into the Impact of the Belgian Health Care Knowledge Centre. Brussels: Belgian Health Care Knowledge Centre; 2010. Poortvliet EP, Vijfvinkel D, Vennekens A, van Hoesel P, Daue F. Study into the Impact of the Belgian Health Care Knowledge Centre. Brussels: Belgian Health Care Knowledge Centre; 2010.
58.
go back to reference RSM McClure Watters, Hanney S, Nason E. Evaluation of the impact of HSC R&D Funding in Northern Ireland, Including Benchmarking with other Countries. Belfast: RSM McClure Watters; 2012. RSM McClure Watters, Hanney S, Nason E. Evaluation of the impact of HSC R&D Funding in Northern Ireland, Including Benchmarking with other Countries. Belfast: RSM McClure Watters; 2012.
60.
go back to reference Shah S, Ward JE. Outcomes from NHMRC public health research project grants awarded in 1993. Aust NZ J Public Health. 2001;25:556–60.CrossRef Shah S, Ward JE. Outcomes from NHMRC public health research project grants awarded in 1993. Aust NZ J Public Health. 2001;25:556–60.CrossRef
61.
go back to reference Soper B, Hanney S. Lessons from the evaluation of the UK's NHS R&D Implementation Methods Programme. Imp Sci. 2007;2:7.CrossRef Soper B, Hanney S. Lessons from the evaluation of the UK's NHS R&D Implementation Methods Programme. Imp Sci. 2007;2:7.CrossRef
62.
go back to reference The Madrillon Group. The Mind–Body Interactions and Health Program Outcome Evaluation. Final Report. Bethesda, MD: Office of Behavioral and Social Sciences Research, National Institutes of Health; 2011. The Madrillon Group. The Mind–Body Interactions and Health Program Outcome Evaluation. Final Report. Bethesda, MD: Office of Behavioral and Social Sciences Research, National Institutes of Health; 2011.
63.
go back to reference Wisely J. Assessment of the benefits from the National R&D Programme on primary/secondary care interface. London: NHS London Regional Office; 2001. Wisely J. Assessment of the benefits from the National R&D Programme on primary/secondary care interface. London: NHS London Regional Office; 2001.
64.
go back to reference Wisely J. National R&D Programme in the area of mother and child: programme report. London: NHS London Regional Office; 2001. Wisely J. National R&D Programme in the area of mother and child: programme report. London: NHS London Regional Office; 2001.
65.
go back to reference Wooding S, Nason E, Starkey T, Hanney S, Grant J. Mapping the Impact: Exploring the Payback of Arthritis Research. Santa Monica, CA: RAND Corporation; 2009. Wooding S, Nason E, Starkey T, Hanney S, Grant J. Mapping the Impact: Exploring the Payback of Arthritis Research. Santa Monica, CA: RAND Corporation; 2009.
68.
go back to reference Buxton M, Hanney S, Jones T. Estimating the economic value to societies of the impact of health research: a critical review. Bull World Health Organ. 2004;82:733–9.PubMedPubMedCentral Buxton M, Hanney S, Jones T. Estimating the economic value to societies of the impact of health research: a critical review. Bull World Health Organ. 2004;82:733–9.PubMedPubMedCentral
69.
go back to reference Spaapen J, Dijstelbloem H, Wamelink F. Evaluating Research in Context. A Method for Comprehensive Assessment. 2nd ed. The Hague: Consultative Committee of Sector Councils for Research and Development; 2007. Spaapen J, Dijstelbloem H, Wamelink F. Evaluating Research in Context. A Method for Comprehensive Assessment. 2nd ed. The Hague: Consultative Committee of Sector Councils for Research and Development; 2007.
73.
go back to reference Mushkin S. Biomedical research: costs and benefits. Cambridge, MA: Ballinger; 1979. Mushkin S. Biomedical research: costs and benefits. Cambridge, MA: Ballinger; 1979.
74.
go back to reference Economics A. Exceptional Returns: The Value of Investing in Health R&D in Australia. Sydney, NSW: Australian Society for Medical Research; 2003. Economics A. Exceptional Returns: The Value of Investing in Health R&D in Australia. Sydney, NSW: Australian Society for Medical Research; 2003.
75.
go back to reference Roback K, Dalal K, Carlsson P. Evaluation of health research: measuring costs and socioeconomic effects. Int J Prev Med. 2011;2:203–15.PubMedPubMedCentral Roback K, Dalal K, Carlsson P. Evaluation of health research: measuring costs and socioeconomic effects. Int J Prev Med. 2011;2:203–15.PubMedPubMedCentral
76.
go back to reference Buxton M, Hanney S, Morris S, Sundmacher L, Mestre-Ferrandiz J, Garau M, et al. Medical Research: What’s it Worth? Estimating the Economic Benefits from Medical Research in the UK. London: UK Evaluation Forum; 2008. Buxton M, Hanney S, Morris S, Sundmacher L, Mestre-Ferrandiz J, Garau M, et al. Medical Research: What’s it Worth? Estimating the Economic Benefits from Medical Research in the UK. London: UK Evaluation Forum; 2008.
79.
go back to reference Guthrie S, Hafner M, Bienkowska-Gibbs T, Wooding S. Returns on research funded under the NIHR Health Technology Assessment (HTA) Programme. Health Technol Assess. 2015;19:67.CrossRef Guthrie S, Hafner M, Bienkowska-Gibbs T, Wooding S. Returns on research funded under the NIHR Health Technology Assessment (HTA) Programme. Health Technol Assess. 2015;19:67.CrossRef
80.
go back to reference Alberta Heritage Foundation for Medical Research (AHFMR). A study of the impact of 2001–2002 health technology assessment products: final report. Edmonton: AHFMR; 2003. Alberta Heritage Foundation for Medical Research (AHFMR). A study of the impact of 2001–2002 health technology assessment products: final report. Edmonton: AHFMR; 2003.
82.
go back to reference Catalan Agency for Health Technology Assessment and Research. Impact Assessment of the TV3 Telethon on Biomedical Research in Catalonia. Barcelona: Fundació La Marató de TV3, Agència d’Avaluació de Tecnologia i Recerca Mèdiques (AATRM); 2006. Catalan Agency for Health Technology Assessment and Research. Impact Assessment of the TV3 Telethon on Biomedical Research in Catalonia. Barcelona: Fundació La Marató de TV3, Agència d’Avaluació de Tecnologia i Recerca Mèdiques (AATRM); 2006.
84.
go back to reference NHS Executive Trent. An evaluation of regional R&D funding schemes in Trent. Sheffield: NHS Executive Trent; 1997. NHS Executive Trent. An evaluation of regional R&D funding schemes in Trent. Sheffield: NHS Executive Trent; 1997.
85.
go back to reference Shani S, Siebzehner MI, Luxenburg O, Shemer J. Setting priorities for the adoption of healthtechnologies on a national level: the Israeli experience. Health Policy. 2000;54:169–85.CrossRefPubMed Shani S, Siebzehner MI, Luxenburg O, Shemer J. Setting priorities for the adoption of healthtechnologies on a national level: the Israeli experience. Health Policy. 2000;54:169–85.CrossRefPubMed
86.
go back to reference Stryer D, Tunis S, Hubbard H, Clancy C. The outcomes of outcomes and effectiveness research: impacts and lessons from the first decade. Health Serv Res. 2000;35(5 Pt 1):977–93.PubMedPubMedCentral Stryer D, Tunis S, Hubbard H, Clancy C. The outcomes of outcomes and effectiveness research: impacts and lessons from the first decade. Health Serv Res. 2000;35(5 Pt 1):977–93.PubMedPubMedCentral
89.
go back to reference Adam T, Røttingen JA, Kieny MP. Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers. Health Res Policy Syst. 2015;13:9.CrossRefPubMedPubMedCentral Adam T, Røttingen JA, Kieny MP. Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers. Health Res Policy Syst. 2015;13:9.CrossRefPubMedPubMedCentral
90.
go back to reference Brennan S, McKenzie JE, Turner T, Redman S, Makkar S, Williamson A, et al. Development and validation of SEER (Seeking, Engaging with and Evaluating Research): a measure of policymakers’ capacity to engage with and use research. Health Res Policy Syst. 2017;15:1.CrossRefPubMedPubMedCentral Brennan S, McKenzie JE, Turner T, Redman S, Makkar S, Williamson A, et al. Development and validation of SEER (Seeking, Engaging with and Evaluating Research): a measure of policymakers’ capacity to engage with and use research. Health Res Policy Syst. 2017;15:1.CrossRefPubMedPubMedCentral
91.
Metadata
Title
The impact on healthcare, policy and practice from 36 multi-project research programmes: findings from two reviews
Authors
Steve Hanney
Trisha Greenhalgh
Amanda Blatch-Jones
Matthew Glover
James Raftery
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2017
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-017-0191-y

Other articles of this Issue 1/2017

Health Research Policy and Systems 1/2017 Go to the issue